Vitamin D receptor and binding protein polymorphisms in women with polycystic ovary syndrome: A case control studyBMC Endocrine Disorders, 2019, v.19 no.1, 145
Association between cadmium and anti-Mullerian hormone in premenopausal women at particular agesAnnals of Occupational and Environmental Medicine, 2018, v.30 no.1, 44
Malignancy Risk and Related Factors of Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance in Thyroid Fine Needle AspirationINTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2018 , 4521984
Differentiation between polycystic ovary syndrome and polycystic ovarian morphology by means of an anti-Mullerian hormone cutoff valueKOREAN JOURNAL OF INTERNAL MEDICINE, 2017, v.32 no.4, 690-698
Polycystic ovary morphology is associated with insulin resistance in women with polycystic ovary syndromeCLINICAL ENDOCRINOLOGY, 2017, v.87 no.4, 375-380
Triglycerides to High-Density Lipoprotein Cholesterol Ratio Can Predict Impaired Glucose Tolerance in Young Women with Polycystic Ovary SyndromeYonsei Medical Journal, 2016, v.57 no.6, 1404~1411
A prospective, randomized, multicenter trial comparing the efficacy and safety of the concurrent use of long-acting insulin with mitiglinide or voglibose in patients with type 2 diabetesEndocrine Journal, 2015, v.62 no.12, 1049-1057
A randomized, double-blind, placebo-controlled, phase II clinical trial to investigate the efficacy and safety of oral DA-1229 in patients with type 2 diabetes mellitus who have inadequate glycaemic control with diet and exerciseDiabetes/Metabolism Research and Reviews, 2015, v.31 no.3
A randomized, placebo-controlled, double-blind, phase 3 trial to evaluate the efficacy and safety of anagliptin in drug-naive patients with type 2 diabetesENDOCRINE JOURNAL, 2015, v.62 no.5, 449-462
Comparison of the efficacy and safety of once-daily dosing and on-demand use of udenafil for type 2 diabetic patients with erectile dysfunctionAsian Journal of Andrology, 2015, v.17 no.1, 143-148
Insulin initiation in insulin-naïve korean type 2 diabetic patients inadequately controlled on oral antidiabetic drugs in real-world practice: The modality of insulin treatment evaluation studyDiabetes and Metabolism Journal, 2015, v.39 no.6, 481-488
Lobeglitazone and pioglitazone as add-ons to metformin for patients with type 2 diabetes: a 24-week, multicentre, randomized, double-blind, parallel-group, active-controlled, phase III clinical trial with a 28-week extensionDIABETES OBESITY & METABOLISM, 2015, v.17 no.6, 599-602
A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, PHASE 3 TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF ANAGLIPTIN IN PATIENTS WITH TYPE 2 DIABETESDIABETES RESEARCH AND CLINICAL PRACTICE, 2014, v.106, S149-S150
Duration of diabetes and effectiveness of insulin in the management of insulin-naïve Korean patients uncontrolled on oral antidiabetic drugs: a sub-analysis of the MOdaliTy of Insulin treatment eValuation (MOTIV) registry resultsActa Diabetologica, 2014, v.51 no.4, 1-7
Evidence for gonadotrophin secretory and steroidogenic abnormalities in brothers of women with polycystic ovary syndromeHUMAN REPRODUCTION, 2014, v.29 no.12, 2764-2772
FTO gene variants are associated with PCOS susceptibility and hyperandrogenemia in young Korean womenDiabetes and Metabolism Journal, 2014, v.38 no.4, 302-310
Hyperandrogenemia is implicated in both the metabolic and reproductive morbidities of polycystic ovary syndromeFERTILITY AND STERILITY, 2014, v.101 no.3, 840-845
INSULIN RESISTANCE ACCORDING TO beta-CELL FUNCTION IN POLYCYSTIC OVARY SYNDROME WOMEN WITH NORMAL GLUCOSE TOLERANCEDIABETES RESEARCH AND CLINICAL PRACTICE, 2014, v.106, S45-S45
Pathway Analysis of Metabolic Syndrome Using a Genome-Wide Association Study of Korea Associated Resource (KARE) CohortsGenomics & Informatics, 2014, 제12권 4호, 195-202